Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Oyi-based therapeutic HIV vaccine reduces the HIV RNA rebound median following cART interruption

April 15, 2016

Mymetics' HIV vaccine candidate shows promise in preclinical study

April 12, 2016

Large, multinational studies of anti-HIV antibody VRC-01 launched by NIH

April 8, 2016

FDA approves Gilead's Descovy for the treatment of HIV

April 5, 2016

Bristol-Myers Squibb discloses inhibitors of HIV replication

April 1, 2016

Shionogi patents HIV protease inhibitors

March 31, 2016

Theratechnologies and TaiMed Biologics sign exclusive agreement for ibalizumab

March 22, 2016

Adjunctive sertraline shows efficacy in treatment of HIV-associated cryptococcal meningitis

March 18, 2016

Northwestern University reports development of APOBEC-3G expression enhancers

March 15, 2016

Bristol-Myers Squibb describes HIV integrase inhibitors

March 11, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...